ACRF provides grants for scientific equipment and other technologies as well as the establishment of capital works and facilities and national enterprises in support of all aspects of cancer research.
ACRF is a ‘seed’ funding body and is therefore interested in applications for larger scale research projects with value over and above the amount sought directly from ACRF. We expect applicants to leverage ACRF grants to secure any ‘gap’ funding and also to feature multi-disciplinary teams, collaborations and evidence of the translational impacts at a clinical level (with patients).
All applications are considered and assessed by our Medical Research Advisory Committee, a group of highly distinguished research scientists who are appointed by ACRF’s Board of Trustees.
The procedures of the Committee are similar to those employed by the National Health and Medical Research Council and include the assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed applicants.
The Committee’s recommendations for funding are reviewed and finalised by the ACRF Board of Trustees.
The ACRF annual grant round is now open. Please download application guidelines below.
A detailed written application can be submitted no later than 5pm (Sydney time) Friday 22 June, 2018.
If you have any questions regarding ACRF grants process, please contact Cheryl Riddington on 1300 884 988 or email@example.com
Previously incurable skin cancers have responded to the new anti-PD1 therapy drug in almost fifty percent of patients on a Peter Mac cl...
A team of cancer researchers at the Walter and Eliza Hall Institute (WEHI) has been recognised for their role in the development of a n...